Repligen (RGEN) Tops Q1 EPS by 5c, Lowers FY23 Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $130.59 -2.06%
Revenue Growth %: +10.7%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +10.7%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.64, $0.05 better than the analyst estimate of $0.59. Revenue for the quarter came in at $182.7 million versus the consensus estimate of $182.19 million.
GUIDANCE:
Repligen sees FY2023 EPS of $2.35-$2.42, versus the consensus of $2.64. Repligen sees FY2023 revenue of $720-760 million, versus the consensus of $780 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Cracker Barrel (CBRL) Tops Q3 EPS by 71c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
